YOLFTbeta
Genetic Signatures Ltd

Genetic Signatures Ltd

GSS · AU · Healthcare / Diagnostics & Research

0.072AUD-0.01 (-6.49%)

Price History

Full chart

Market Stats

Previous Close0.077
Open0.076
Day Range0.067 – 0.076
52-Week Range0.051 – 0.43
Volume255.71K
Market Cap17.94M
P/E (TTM)0.00
Forward P/E52.36
EPS-0.06
Dividend Yield0.00%
Beta0.58
50-Day Avg0.0715
200-Day Avg0.1032

About

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMs. Maria Halasz BSc, MBA
  • Employees0
  • HeadquartersHeart Research Institute, Newtown, NSW, Australia, 2042, Australia
  • Websitehttps://www.geneticsignatures.com

Leadership

  • Ms. Maria Halasz BSc, MBAChief Executive Officer
  • Mr. Christopher M. Abbott A.M., F.C.A., Ph.D., Ph.D., (Hon)Founder & Chairman Emeritus
  • Ms. Angela WangFinancial Controller
  • Dr. Susanne K. Pedersen Ph.D.Chief Technology Officer
  • Ms. Rebecca AbbatantuonoChief People Officer
  • Ms. Sonya Tissera?Isaacs C.S.Company Secretary

Financials

Income Statement

Currency: AUD2012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue220.00K256.98K1.29M1.04M3.27M4.06M4.99M7.02M11.26M28.28M35.42M16.94M9.77M15.90M14.45M
Growth (%)-+16.81%+402.97%-19.28%+213.03%+24.37%+22.95%+40.66%+60.35%+151.12%+25.23%-52.18%-42.35%+62.81%-9.10%
Cost of Revenue525.00K397.99K606.70K395.15K1.02M1.72M1.98M2.86M13.63M24.01M28.21M29.68M5.46M8.12M27.18M
Gross Profit--141.01K685.83K648.12K2.25M2.34M3.01M4.16M-2.37M4.27M7.21M-12.74M4.31M7.78M-12.72M
Gross Margin--54.87%53.06%62.12%68.89%57.56%60.29%59.27%-21.00%15.10%20.36%-75.21%44.11%48.95%-88.02%
Operating Expense-2.12M1.92M3.75M5.25M5.12M6.41M7.76M2.46M2.71M4.25M6.15M26.64M26.26M5.02M
Operating Income--2.26M-1.23M-3.11M-3.00M-2.78M-3.40M-3.60M-4.83M1.56M2.97M-18.89M-22.33M-18.48M-17.74M
Operating Margin--879.85%-95.54%-297.78%-91.80%-68.52%-68.05%-51.24%-42.88%5.50%8.38%-111.52%-228.68%-116.23%-122.76%
EBITDA--2.21M-2.23M-2.38M-2.60M-2.30M-2.77M-3.02M-1.17M3.22M4.70M-13.14M-19.82M-16.08M-15.68M
EBITDA Margin--858.05%-172.75%-228.12%-79.57%-56.74%-55.40%-43.01%-10.39%11.37%13.26%-77.56%-202.99%-101.11%-108.49%
Net Income--2.01M-1.73M-2.66M-3.03M-2.67M-3.25M-3.49M-2.09M1.76M3.06M-14.05M-17.86M-20.10M-14.01M
Net Income Margin--783.88%-133.73%-254.88%-92.68%-65.75%-65.16%-49.72%-18.52%6.21%8.65%-82.96%-182.90%-126.44%-96.91%
R&D--------------148.00K
R&D as % of Total Revenue--------------1.02%
Interest Expense0293.33K04541.13K42352551933.00K36.00K19.00K1.00K35.00K91.00K46.00K
Interest Expense % of Total Revenue0.00%114.15%0.00%0.04%0.03%0.01%0.01%0.01%0.29%0.13%0.05%0.01%0.36%0.57%0.32%

Balance Sheet

Currency: AUD2013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets914.85K16.55M7.80M5.96M17.67M14.61M12.13M49.72M54.05M59.65M49.08M67.29M54.63M38.46M
Total Liabilities4.23M370.48K743.14K1.28M1.19M1.21M1.56M3.79M4.71M4.85M6.16M6.18M4.54M2.73M
Total Equity-3.32M16.18M7.06M4.68M16.49M13.40M10.57M45.93M49.34M54.80M42.91M61.10M50.09M35.72M
Cash147.47K15.42M5.46M2.56M13.19M8.95M6.31M31.18M30.12M36.90M16.35M36.25M7.47M9.07M
Total Debt3.92M-----741.00K741.00K399.00K34.00K-1.22M791.00K310.00K
Net Debt3.78M-15.42M-5.46M-2.56M-13.19M-8.95M-6.31M-30.43M-29.72M-36.86M-16.35M-35.03M-6.68M-8.76M

Cash Flow

Currency: AUD2012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--1.19M-1.35M-2.80M-2.57M-2.57M-3.69M-2.27M-9.49M4.20M9.81M-12.45M-10.12M-12.29M-7.77M
Investing Cash Flow--69.38K-380.83K-551.68K-371.17K-1.01M-519.37K-610.00K-2.35M-4.98M-2.99M-8.09M-4.79M-24.30M9.85M
Financing Cash Flow750.00K1.00M3.44M6.96M46.05K14.23M250.00K250.00K36.69M-190.00K-101.00K-23.00K34.81M7.79M-481.00K
Capital Expenditure62.00K69.38K380.83K551.68K371.17K1.01M519.37K610.00K2.35M4.98M2.99M8.09M4.79M902.00K1.05M
Free Cash Flow--1.26M-1.74M-3.35M-2.94M-3.58M-4.21M-2.88M-11.84M-784.00K6.82M-20.55M-14.91M-13.19M-8.82M
Dividends Paid--------34.79M202.00K110.00K24.00K---
FCF to OCF-105.85%128.11%119.74%114.43%139.33%114.06%126.88%124.75%-18.69%69.52%165.01%147.34%107.34%113.49%
Dividend Paid to FCF---------293.77%-25.77%1.61%-0.12%---

Earnings

Report DateFeb 26, 2016Sep 28, 2016Feb 27, 2017Aug 30, 2017Feb 27, 2018Aug 28, 2018Feb 24, 2019Jul 24, 2019Feb 25, 2020Aug 27, 2020Dec 2, 2020Feb 21, 2021Jun 2, 2021Aug 24, 2021Oct 24, 2021Feb 17, 2022Jun 1, 2022Aug 31, 2022Oct 27, 2022Feb 21, 2023May 31, 2023Aug 30, 2023Nov 29, 2023Feb 21, 2024May 29, 2024Aug 30, 2024Nov 27, 2024Feb 25, 2025May 28, 2025Aug 29, 2025Oct 20, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.00-0.000.000.00-0.00-0.000.000.000.000.000.000.000.000.00-0.00
EPS Actual-0.02-0.02-0.02-0.02-0.02-0.01-0.02-0.02-0.020.000.000.030.00-0.020.000.030.00-0.010.00-0.050.000.000.000.000.000.000.00-0.070.00-0.020.00
Surprise-------------------------------
Timing-------Pre-marketAfter-hoursAfter-hours-After-hours-After-hours-After-hours-Pre-marketPre-marketAfter-hours-After-hours-------Pre-market-

Key Statistics & Ratios

Market Cap17.94M
Enterprise Value-4.07M
Trailing P/E0.00
Forward P/E52.36
Price / Sales0.93
Price / Book0.50
EPS-0.06
Book Value0.157
Revenue (TTM)19.33M
Gross Profit (TTM)8.61M
EBITDA-11.27M
Profit Margin-72.45%
Operating Margin-56.40%
Return on Equity-32.64%
Return on Assets-17.27%
Shares Outstanding227.14M
Shares Float138.63M
Beta0.58
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
40.80%
Insiders
28.24%
Retail / Other
30.96%

Top Fund Holders

  • Alps Series Tr-Seven Canyons World Innovators Fd
    1.10M0.77%